EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PSMA-targeted delivery of docetaxel in prostate cancer using small-sized PDA-based micellar nanovectors

Cristian Rosales-Barrios, Zaira I González-Sánchez, Alessio Zuliani, Juan M Jiménez-Vacas, Raul M Luque, David Pozo, Noureddine Khiar

Journal of Controlled Release · 2025-03 · 379 · 890-905

DOI: 10.1016/j.jconrel.2025.01.062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2025-03. Verfasst von Cristian Rosales-Barrios und 6 weiteren Autor:innen. Beteiligte Einrichtung: Asymmetric Synthesis and Functional Nanosystems Group (Art&Fun), Institute of Chemical Research (IIQ), CSIC-University of Seville, C/ Américo Vespuci…. Hauptthemen laut MEDLINE: Docetaxel, Prostatic Neoplasms, Glutamate Carboxypeptidase II, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, Consejo Superior de Investigaciones Científicas, Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we present the first comparative analysis of active and passive drug delivery systems for docetaxel (DTX) in prostate cancer using supramolecular self-assembled micellar nanovectors. Specifically, we developed two novel micelles based on polydiacetylenic amphiphiles (PDA) for passive and active targeting. The active targeting micelles were designed with a prostate-specific membrane antigen (PSMA) ligand, ACUPA, to facilitate recognition by PSMA-positive cancer cells. These PDA-based micelles feature a well-defined structure with a hydrophobic PDA core and a surface functionalized with PEG, and for active targeting, ACUPA. Our micelles demonstrated excellent encapsulation capacity, significantly improving DTX solubility in water, a crucial factor for clinical drug use. In vitro studies confirmed the safety and cytotoxic profiles of both systems, with ACUPA-functionalized micelles showing notable internalization into PSMA-positive LNCaP cells, mediated through the PSMA-ACUPA interaction. In vivo imaging revealed preferential accumulation of ACUPA-functionalized nanomicelles in LNCaP xenograft tumors, suggesting enhanced retention via specific ACUPA-PSMA interactions and active uptake by LNCaP cells. Notably, Balb/c-Foxn1nu/nu early in vivo studies showed a marked reduction in tumor volume and tumor expression levels of proliferation, cell cycle progression, cell survival and anti-apoptotic markers with DTX-loaded micelles functionalized with ACUPA compared to those without ACUPA. Overall, our studies collect initial evidence regarding the feasibility of supramolecular self-assembly of ACUPA-PDA-based nanomicelles for PSMA-targeted drug chemotherapy delivery developments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DocetaxelProstatic NeoplasmsGlutamate Carboxypeptidase IIAntineoplastic AgentsAntigens, SurfacePolymersMaleHumansMicellesAnimalsCell Line, TumorMice, NudeDrug Delivery SystemsMiceMice, Inbred BALB CNanoparticles

Stichwörter der Autor:innen

Active targetingPSMAPassive targetingProstate cancerStable Supramolecular Micelles

Substanzen

DocetaxelMicellesGlutamate Carboxypeptidase IIAntineoplastic AgentsFOLH1 protein, humanAntigens, SurfacePolymers

Autor:innen und Institutionen

  • Asymmetric Synthesis and Functional Nanosystems Group (Art&Fun), Institute of Chemical Research (IIQ), CSIC-University of Seville, C/ Américo Vespucio 49, 41092 Seville, Spain.
  • Department of Integrative Pathophysiology and Therapies, Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER), CSIC-Universidad Pablo de Olavide-Universidad de Sevilla, Av. Americo Vespucio 24, Se…
  • Maimónides Institute for Biomedical Research of Córdoba (IMIBIC), University Hospital Reina Sofía (HURS), Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBERobn), Av. Menéndez Pi…
  • Asymmetric Synthesis and Functional Nanosystems Group (Art&Fun), Institute of Chemical Research (IIQ), CSIC-University of Seville, C/ Américo Vespucio 49, 41092 Seville, Spain. Electronic address: khiar@iiq.csic.es.

Förderung

  • Ministerio de Ciencia e Innovación
  • Consejo Superior de Investigaciones Científicas
  • Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía
  • European Social Fund Plus
  • Federación Española de Enfermedades Raras
  • European Regional Development Fund
  • Junta de Andalucía

Zitieren

APA

Rosales-Barrios, C., González-Sánchez, Z. I., Zuliani, A., Jiménez-Vacas, J. M., Luque, R. M., Pozo, D., & Khiar, N. (2025). PSMA-targeted delivery of docetaxel in prostate cancer using small-sized PDA-based micellar nanovectors. Journal of Controlled Release, 379, 890-905. https://doi.org/10.1016/j.jconrel.2025.01.062

Vancouver

Rosales-Barrios C, González-Sánchez ZI, Zuliani A, Jiménez-Vacas JM, Luque RM, Pozo D, et al. PSMA-targeted delivery of docetaxel in prostate cancer using small-sized PDA-based micellar nanovectors. Journal of Controlled Release. 2025;379:890-905. doi:10.1016/j.jconrel.2025.01.062

BibTeX
@article{RosalesBarrios2025,
  author = {Rosales-Barrios, Cristian and González-Sánchez, Zaira I and Zuliani, Alessio and Jiménez-Vacas, Juan M and Luque, Raul M and Pozo, David and Khiar, Noureddine},
  title = {PSMA-targeted delivery of docetaxel in prostate cancer using small-sized PDA-based micellar nanovectors},
  journal = {Journal of Controlled Release},
  year = {2025},
  volume = {379},
  pages = {890--905},
  doi = {10.1016/j.jconrel.2025.01.062}
}
Kostenlos starten →